These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

413 related articles for article (PubMed ID: 17065899)

  • 1. Do antifibrinolytics reduce allogeneic blood transfusion in orthopedic surgery?
    Zufferey P; Merquiol F; Laporte S; Decousus H; Mismetti P; Auboyer C; Samama CM; Molliex S
    Anesthesiology; 2006 Nov; 105(5):1034-46. PubMed ID: 17065899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion.
    Henry DA; Carless PA; Moxey AJ; O'Connell D; Stokes BJ; Fergusson DA; Ker K
    Cochrane Database Syst Rev; 2011 Jan; (1):CD001886. PubMed ID: 21249650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion.
    Henry DA; Carless PA; Moxey AJ; O'Connell D; Stokes BJ; McClelland B; Laupacis A; Fergusson D
    Cochrane Database Syst Rev; 2007 Oct; (4):CD001886. PubMed ID: 17943760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion.
    Henry DA; Carless PA; Moxey AJ; O'Connell D; Stokes BJ; Fergusson DA; Ker K
    Cochrane Database Syst Rev; 2011 Mar; 2011(3):CD001886. PubMed ID: 21412876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of antifibrinolytic agents on surgical bleeding and transfusion requirements in spine surgery: a meta-analysis.
    Li G; Sun TW; Luo G; Zhang C
    Eur Spine J; 2017 Jan; 26(1):140-154. PubMed ID: 27671279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antifibrinolytics in major orthopaedic surgery.
    Eubanks JD
    J Am Acad Orthop Surg; 2010 Mar; 18(3):132-8. PubMed ID: 20190103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antifibrinolytic therapy for preventing oral bleeding in patients with haemophilia or Von Willebrand disease undergoing minor oral surgery or dental extractions.
    van Galen KP; Engelen ET; Mauser-Bunschoten EP; van Es RJ; Schutgens RE
    Cochrane Database Syst Rev; 2015 Dec; (12):CD011385. PubMed ID: 26704192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drugs to minimize perioperative blood loss in cardiac surgery: meta-analyses using perioperative blood transfusion as the outcome. The International Study of Peri-operative Transfusion (ISPOT) Investigators.
    Laupacis A; Fergusson D
    Anesth Analg; 1997 Dec; 85(6):1258-67. PubMed ID: 9390590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The safety of aprotinin and lysine-derived antifibrinolytic drugs in cardiac surgery: a meta-analysis.
    Henry D; Carless P; Fergusson D; Laupacis A
    CMAJ; 2009 Jan; 180(2):183-93. PubMed ID: 19050037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of antifibrinolytic agents in spinal surgery: a network meta-analysis.
    Yuan L; Zeng Y; Chen ZQ; Zhang XL; Mai S; Song P; Tao LY
    Chin Med J (Engl); 2019 Mar; 132(5):577-588. PubMed ID: 30807356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion.
    Henry DA; Moxey AJ; Carless PA; O'Connell D; McClelland B; Henderson KM; Sly K; Laupacis A; Fergusson D
    Cochrane Database Syst Rev; 2001; (1):CD001886. PubMed ID: 11279735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epsilon-aminocaproic acid versus tranexamic acid in total knee arthroplasty: a meta-analysis study.
    Riaz O; Aqil A; Asmar S; Vanker R; Hahnel J; Brew C; Grogan R; Radcliffe G
    J Orthop Traumatol; 2019 Jul; 20(1):28. PubMed ID: 31321578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risks of harms using antifibrinolytics in cardiac surgery: systematic review and network meta-analysis of randomised and observational studies.
    Hutton B; Joseph L; Fergusson D; Mazer CD; Shapiro S; Tinmouth A
    BMJ; 2012 Sep; 345():e5798. PubMed ID: 22968722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is epsilon-aminocaproic acid as effective as aprotinin in reducing bleeding with cardiac surgery?: a meta-analysis.
    Munoz JJ; Birkmeyer NJ; Birkmeyer JD; O'Connor GT; Dacey LJ
    Circulation; 1999 Jan 5-12; 99(1):81-9. PubMed ID: 9884383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of aprotinin, tranexamic acid, and aminocaproic acid on blood loss and use of blood products in major pediatric surgery: a meta-analysis.
    Schouten ES; van de Pol AC; Schouten AN; Turner NM; Jansen NJ; Bollen CW
    Pediatr Crit Care Med; 2009 Mar; 10(2):182-90. PubMed ID: 19188875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tranexamic acid and aprotinin in low- and intermediate-risk cardiac surgery: a non-sponsored, double-blind, randomised, placebo-controlled trial.
    Later AF; Maas JJ; Engbers FH; Versteegh MI; Bruggemans EF; Dion RA; Klautz RJ
    Eur J Cardiothorac Surg; 2009 Aug; 36(2):322-9. PubMed ID: 19250838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of intravenous tranexamic acid to reduce allogeneic blood transfusion in total hip and knee arthroplasty: a meta-analysis.
    Ho KM; Ismail H
    Anaesth Intensive Care; 2003 Oct; 31(5):529-37. PubMed ID: 14601276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antifibrinolytics (lysine analogues) for the prevention of bleeding in patients with haematological disorders.
    Wardrop D; Estcourt LJ; Brunskill SJ; Doree C; Trivella M; Stanworth S; Murphy MF
    Cochrane Database Syst Rev; 2013 Jul; (7):CD009733. PubMed ID: 23897323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antifibrinolytic drugs for acute traumatic injury.
    Ker K; Roberts I; Shakur H; Coats TJ
    Cochrane Database Syst Rev; 2015 May; 2015(5):CD004896. PubMed ID: 25956410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological strategies to decrease excessive blood loss in cardiac surgery: a meta-analysis of clinically relevant endpoints.
    Levi M; Cromheecke ME; de Jonge E; Prins MH; de Mol BJ; Briët E; Büller HR
    Lancet; 1999 Dec; 354(9194):1940-7. PubMed ID: 10622296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.